mariatkach-istockphoto-com-spain-
MariaTkach / iStockphoto.com
27 March 2017AmericasJosé Manuel González

New rules for SPCs in Spain

Supplementary protection certificates (SPCs) were created in the EU to offer additional protection to medicinal patents for human and veterinary use and for phytosanitary products, which are used to fight infections and pests that affect plants. This supplementary protection extends that conferred by the base patent to the product covered by the marketing authorisation for a specific period, which shall be a maximum of five years.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
9 January 2026   A busy week in US courts saw major pharma companies and biotech firms move to protect key therapies and research tools, with new lawsuits over migraine and cancer drug generics, and alleged misuse of COVID-19 vaccine tech.
Americas
8 January 2026   Important questions about when companies must act on suspicions of theft and whether damages can stack with injunctions were raised in a dispute that has already sent ripples across med tech.
Americas
8 January 2026   Crop science division alleges that vaccine developers used patented mRNA stability technology in shots that earned them around $140 billion in global sales.